1. Home
  2. CNK vs ABCL Comparison

CNK vs ABCL Comparison

Compare CNK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

SELL

Current Price

$40.02

Market Cap

4.5B

ML Signal

SELL

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

SELL

Current Price

$11.21

Market Cap

4.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CNK
ABCL
Founded
1984
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.1B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CNK
ABCL
Price
$40.02
$11.21
Analyst Decision
Buy
Strong Buy
Analyst Count
11
13
Target Price
★ $42.09
$17.17
AVG Volume (30 Days)
1.8M
★ 3.8M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 0.89%
N/A
EPS Growth
N/A
★ 10.91
EPS
★ N/A
N/A
Revenue
★ $3,115,000,000.00
$75,128,000.00
Revenue This Year
$18.24
N/A
Revenue Next Year
$1.07
$7.12
P/E Ratio
★ N/A
N/A
Revenue Growth
2.15
★ 160.56
52 Week Low
$21.60
$2.75
52 Week High
$40.75
$14.98

Technical Indicators

Market Signals
Indicator
CNK
ABCL
Relative Strength Index (RSI) 62.09 49.85
Support Level $34.40 $11.78
Resistance Level $40.53 $12.88
Average True Range (ATR) 1.42 0.90
MACD -0.05 -0.06
Stochastic Oscillator 91.40 43.72

Price Performance

Historical Comparison
CNK
ABCL

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: